These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 5422909)

  • 1. Fibrocystic disease in women receiving oral contraceptive hormones.
    Fechner RE
    Cancer; 1970 Jun; 25(6):1332-9. PubMed ID: 5422909
    [No Abstract]   [Full Text] [Related]  

  • 2. [Anatomo--surgical data on fibrocystic mastopathy].
    Teramo A; Ruggiero A; Sica GS
    G Ital Chir; 1970; 26(1):65-83. PubMed ID: 5519876
    [No Abstract]   [Full Text] [Related]  

  • 3. Fibrocystic breast disease: pathophysiology, pathomorphology, clinical picture, and management.
    Vorherr H
    Am J Obstet Gynecol; 1986 Jan; 154(1):161-79. PubMed ID: 3511705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exogenous hormone use and fibrocystic breast disease by histopathologic component.
    Berkowitz GS; Kelsey JL; LiVolsi VA; Merino MJ; Holford TR; Hildreth NG; Ort S; O'Connor TZ; White C
    Int J Cancer; 1984 Oct; 34(4):443-9. PubMed ID: 6490201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptive use and fibrocystic breast disease with special reference to its histopathology.
    Pastides H; Kelsey JL; LiVolsi VA; Holford TR; Fischer DB; Goldenberg IS
    J Natl Cancer Inst; 1983 Jul; 71(1):5-9. PubMed ID: 6575209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benign breast tumor and estrogenic hormones: a population-based retrospective study.
    Nomura A; Comstock GW
    Am J Epidemiol; 1976 May; 103(5):439-44. PubMed ID: 179318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relation between component parts of fibrocystic disease complex and breast cancer.
    Page DL; Vander Zwaag R; Rogers LW; Williams LT; Walker WE; Hartmann WH
    J Natl Cancer Inst; 1978 Oct; 61(4):1055-63. PubMed ID: 279711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The surgical pathology of the reproductive system and breast during oral contraceptive therapy.
    Fechner RE
    Pathol Annu; 1971; 6():299-319. PubMed ID: 4949369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibrocystic breast disease in oral-contraceptive users. A histopathological evaluation of epithelial atypia.
    LiVolsi VA; Stadel BV; Kelsey JL; Holford TR; White C
    N Engl J Med; 1978 Aug; 299(8):381-5. PubMed ID: 566853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study of the importance of fibrocystic mastopathy as a precancerous lesion].
    Napolitano A; Di Curzio B; Stella S
    Ann Ital Chir; 1973-1974; 48(3-4):265-76. PubMed ID: 4378000
    [No Abstract]   [Full Text] [Related]  

  • 11. Fibrocystic disease of the breast is not premalignant.
    Devitt JE
    Surg Gynecol Obstet; 1972 May; 134(5):803-6. PubMed ID: 5031493
    [No Abstract]   [Full Text] [Related]  

  • 12. Histologic types of benign breast disease and the risk for breast cancer. The Cancer and Steroid Hormone Study Group.
    McDivitt RW; Stevens JA; Lee NC; Wingo PA; Rubin GL; Gersell D
    Cancer; 1992 Mar; 69(6):1408-14. PubMed ID: 1540878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the possible relationship between oral contraceptives and benign and malignant breast disease.
    Vessey MP; Doll R; Sutton PM
    Cancer; 1971 Dec; 28(6):1395-9. PubMed ID: 5127791
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral contraceptives and breast neoplasia.
    Cole PT
    Cancer; 1977 Apr; 39(4 Suppl):1906-8. PubMed ID: 856458
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral contraceptive use and fibrocystic breast disease among pre- and postmenopausal women.
    Berkowitz GS; Kelsey JL; LiVolsi VA; Holford TR; Merino MJ; Ort S; O'Connor TZ; Goldenberg IS; White C
    Am J Epidemiol; 1984 Jul; 120(1):87-96. PubMed ID: 6741927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Oral contraceptive therapy and breast diseases, a morphological study (author's transl)].
    Prechtel K; Seidel H
    Verh Dtsch Ges Pathol; 1972; 56():529-32. PubMed ID: 4130887
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effects of hormonal contraception on benign changes of the breast].
    De Cecco L; Ragni N; Boccardo E; Viglino S
    Minerva Ginecol; 1982 Nov; 34(11):889-94. PubMed ID: 6818496
    [No Abstract]   [Full Text] [Related]  

  • 18. [Histochemical study of breast cystic dysplasias and fibroadenomas].
    Hernández F
    Rev Med Univ Navarra; 1971 Sep; 15(3):167-71. PubMed ID: 4114904
    [No Abstract]   [Full Text] [Related]  

  • 19. [Oral contraceptives and risk of benign tumors of the breast: recent data from the literature].
    Simard A
    Union Med Can; 1977 Aug; 106(8):1115-9. PubMed ID: 333686
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of benign breast lesions: lack of association with oral contraceptive use.
    Sartwell PE; Arthes FG; Tonascia JA
    N Engl J Med; 1973 Mar; 288(11):551-4. PubMed ID: 4685452
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.